Five highly potent compounds that show promise as potential Parkinson’s disease treatments have been identified by researchers, who massively accelerated the search for them using artificial intelligence techniques. The University of Cambridge scientists say it is “exciting time” in drug discovery, with their machine learning method speeding up the initial screening process tenfold – and reducing the cost by a thousand-fold. This approach could help get potential treatments to Parkinson’s patients much more quickly. One in 37 people alive in the UK today is expected to be diagnosed with Parkin…
